PATENT CLAIM ANALYSIS

Application Number: 15752507
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "604000"]

Abstract:
In one aspect, the present invention provides a method of inhibiting proliferation of a multiple myeloma cell, the method comprising contacting the cell with BRD9647, thereby inhibiting proliferation of the cell. In another aspect, the present invention provides a method of treating multiple myeloma in a pre-selected subject, the method comprising administering an effective amount of BRD9647 to the subject, wherein the subject is pre-selected by detecting a mutation in an AZIN1 polynucleotide or polypeptide relative to a reference in a biological sample obtained from the subject. In another aspect, the present invention provides a method of modulating benzoylation of an agent in a cell, the method comprising contacting the cell with BRD9647, thereby modulating benzoylation of an agent in the cell.

Claim (Index 23):
The method of  claim 22 , wherein the method identifies the subject as sensitive to BRD9647 or a compound of  claim 1 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 2.68
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14044457', '12086792', '13520619', '14670088', '14606938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7733892345342546
- 35 USC 102 Novelty (BERT): 0.5062460974038956
- Combined Prediction Score: 0.7466749208212187
- Mean Citation Score: 225.917774
- Max Citation Score: 230.53688
- Similarity Product: 144.41659983049394

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test